MindWalk launches ReefIQ to integrate biological data for AI drug discovery
MindWalk Holdings Corp. introduced ReefIQ, a HYFT-powered biological context layer designed to harmonize fragmented drug-discovery data for AI-enabled workflows. The platform integrates sequences, structures, and program history into a governed context, supported by a Knowledge Graph of 660 million patterns. CEO Dr. Jennifer Bath highlighted that preserving context from all programs ensures trustworthy reasoning in regulated environments.

*this image is generated using AI for illustrative purposes only.
MindWalk Holdings Corp. has launched ReefIQ, a biological context layer designed to integrate fragmented discovery data for AI-enabled drug discovery and biologics development. The platform addresses the disconnect between connected biology and fragmented drug-discovery data by linking representations before AI workflows act on them. By transforming sequences, structures, assay outputs, omics, literature, and program history into a governed, queryable context, ReefIQ aims to preserve insights from all programs, including those that fail, to support trustworthy reasoning in regulated settings.
Technology Architecture
ReefIQ operates as a client biological context layer built on MindWalk's core HYFT biological pattern technology. HYFT provides the underlying biological representation foundation with explicit relationships across sequence, structure, function, mechanism, pathway, evidence, and literature. The system is supported by a Knowledge Graph comprising 660 million biological patterns and 25 billion relationships, refined over 20 years of curation.
| Component | Function |
|---|---|
| HYFT | Provides the biological representation foundation. |
| ReefIQ | Organizes and governs the client biological context layer. |
| LensAI | Applies reasoning workflows to the connected context. |
Strategic Importance
Dr. Jennifer Bath, PhD, CEO and President of MindWalk Holdings Corp., emphasized that the durable advantage in life-sciences AI lies in the biological context available for reasoning. "Biology is connected by evolutionary constraint; discovery data arrives fragmented across files and systems, and that gap is where insight is lost," said Bath. "ReefIQ is designed to close it, preserving what every program learns as governed context rather than isolated files. In a regulated setting, that is what makes reasoning trustworthy."
Operational Workflow
The platform allows LensAI and customer-selected agent models to retrieve, analyze, and generate hypotheses from connected biological context rather than isolated files. Dirk Van Hyfte, MD, PhD, Chief Technology Officer of MindWalk, stated that the goal is to support retrieval, analysis, and hypothesis generation over connected biological context while preserving provenance, deployment flexibility, and customer-defined controls. LensAI is currently in contracted, recurring arrangements with life-sciences customers.
How will ReefIQ's ability to preserve insights from failed programs impact the overall cost and timeline of future drug discovery efforts?
What are the potential challenges in gaining regulatory approval for AI reasoning workflows that rely on this governed biological context layer?
How does MindWalk plan to scale the Knowledge Graph to accommodate the rapid growth of new biological data and literature?
























